AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 19036752
Drug: Once-daily lamivudine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily lamivudine, tenofovirDF and nevirapine (Group 2)
Trial: 19036752
Drug: Zidovudine/lamivudine and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zidovudine/lamivudine and nevirapine twice daily (Group 1)
Trial: 17156512
Drug: Standard pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard pain treatment
Trial: 16013662
Drug: 0.25 microg
RxNorm normalized name: calcitriol 0.25 MICROGRAM In 1 CAPSULE ORAL CAPSULE, LIQUID FILLED [Rocaltrol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 microg kg(‐1) remifentanil + propofol 2 mg kg(‐1)
Trial: 16013662
Drug: 0.50 microg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.50 microg kg(‐1) remifentanil + propofol 2 mg kg(‐1)
Trial: 1921784
Drug: Sublingual apomorphine
RxNorm normalized name: apomorphine Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual apomorphine (10-30 mg)
Trial: 1921784
Drug: Subcutaneous apomorphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous apomorphine (1-3 mg)
Trial: 1921784
Drug: Oral levodopa
RxNorm normalized name: Levodopa
DrugBank: Levodopa (DB01235)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Oral levodopa
Trial: 6405444
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg IV naloxone
Trial: 19852288
Drug: Gulling Pa'an
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gulling Pa'an Capsule (GPC) in group A
Trial: 19852288
Drug: Gulling Pa'an
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gulling Pa'an Capsule + Levodopa in group C
Trial: 19852288
Drug: Gulling Pa'an
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gulling Pa'an Capsule + Levodopa in group E
Trial: 19852288
Drug: Levodopa dosage
RxNorm normalized name: Levodopa
DrugBank: Levodopa (DB01235)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levodopa dosage in groups C and E
Trial: 15037889
Drug: 0.005% latanoprost
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.005% latanoprost instillation once daily in the morning
Trial: 15037889
Drug: 0.5% timolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% timolol instillation twice daily
Trial: 9687551
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A supplementation (60 mg of oily solution of retinyl palmitate, 30 mg if aged <12 mo) every 6 mo
Trial: 3141143
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (10 mg/kg/d for those weighing less than 6 kg and 50 mg daily for those over 6 kg)
Trial: 31898518
Drug: Ketogenic Diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketogenic Diet (KD) with a restricted carbohydrate intake of 20-40 g/day
Trial: 23842003
Drug: Hib vaccination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hib vaccination via vastus lateralis muscle (2 or 3 times at monthly intervals)
Trial: 22216717
Drug: Carprofen (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carprofen (all doses combined)
Trial: 8985763
Drug: Concurrent control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent control (unintentionally not treated)
Trial: 29077149
Drug: Routine drug
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine drug therapy (Control)
Trial: 25042302
Drug: Massage therapy
RxNorm normalized name: CAMPHOR (SYNTHETIC) 30 g in 1 mL / MENTHOL 40 g in 1 mL TOPICAL OIL [CBDMEDIC MASSAGE THERAPY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Massage therapy plus topical analgesic
Trial: 22313547
Drug: Open treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open treatment with venlafaxine xr 150 mg/day and supportive management (SM)
Trial: 20049491
Drug: Gabapentin (GBT)
RxNorm normalized name: Gabapentin
DrugBank: Gabapentin (DB00996)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gabapentin (GBT) 300 mg
Trial: 20049491
Drug: Ropinirole (ROP)
DrugBank: Ropinirole (DB00268)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ropinirole (ROP) 0.5 mg
Trial: 16293863
Drug: Epirubicin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epirubicin plus paclitaxel (EP) - epirubicin 75 mg/m2 and paclitaxel 200 mg/m2
Trial: 8602382
Drug: Sucralfate 1
RxNorm normalized name: sucralfate 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucralfate 1 g 4 times/day
Trial: 8602382
Drug: Ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 300 mg at bedtime plus sucralfate 1 g 4 times/day
Trial: 16696806
Drug: 300 mL
RxNorm normalized name: HYQVIA 30 GM / 300 ML Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mL white wine
Trial: 16696806
Drug: 500 mL
RxNorm normalized name: TPN Bag 500 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mL beer
Trial: 19809326
Drug: Lidocaine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (100 mg)
Trial: 27223128
Drug: Oral hygiene
RxNorm normalized name: HYDROGEN PEROXIDE 2.94 mL in 2.94 mL ORAL SPRAY [OROXID Forte Oral Hygiene]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral hygiene instructions, subgingival scaling and root planing
Trial: 10454691
Drug: Nimodipine (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimodipine (60 mg taken orally every 4 hours)
Trial: 10454691
Drug: Magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Magnesium sulfate (6 g bolus and 2 g/hr intravenous infusion)
Trial: 25596476
Drug: Maintenance tocolysis
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance tocolysis with nifedipine (exact dosage and duration not specified)
Trial: 23663341
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment of remifemin (one tablet twice daily) and paroxetine (20 mg once daily) for 2 months
Trial: 23663341
Drug: Paroxetine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine (20 mg once daily) for 2 months
Trial: 18949459
Drug: Ketamine (n
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (n = 19; mean ketamine blood plasma = 175.29 ng/mL)
Trial: 9778002
Drug: Fentanyl 10
RxNorm normalized name: FENTANYL 100MCG/HR PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 10 ng/ml (group MF)
Trial: 9778002
Drug: Fentanyl 15
RxNorm normalized name: fentaNYL 150 mcg/30 mL-D5% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 15 ng/ml (group HF)
Trial: 3280855
Drug: Aluminum-containing compounds
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aluminum-containing compounds
Trial: 27797282
Drug: Standard needle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard needle injection
Trial: 37868
Drug: Acebutolol (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acebutolol (400 mg)
Trial: 31718254
Drug: Lisdexamfetamine dimesylate
RxNorm normalized name: Lisdexamfetamine Dimesylate
DrugBank: Lisdexamfetamine (DB01255)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lisdexamfetamine dimesylate (LDX) 30 mg/day
Trial: 22708519
Drug: Family drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Family drug abstinence
Trial: 20179658
Drug: Albuterol HFA
RxNorm normalized name: Albuterol Sulfate 0.09 MG/1 ACTUATION Inhalation Aerosol Powder [ALBUTEROL HFA]
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol HFA 180 microg
Trial: 20179658
Drug: Albuterol HFA
RxNorm normalized name: Albuterol Sulfate 0.09 MG/1 ACTUATION Inhalation Aerosol Powder [ALBUTEROL HFA]
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol HFA 360 microg
Trial: 17343553
Drug: Stimulant to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stimulant to Atomoxetine switch
Trial: 8646094
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose bupivacaine
Trial: 1538159
Drug: rgp160 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rgp160 vaccine (40 micrograms, three doses on days 0, 30, and 180)
Trial: 8817830
Drug: Hepatitis B
RxNorm normalized name: HEPATITIS B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis B vaccine (control)
Trial: 1538159
Drug: Sera from
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sera from HIV-1 antibody-negative volunteers (before vaccination)
Trial: 18614736
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (15 mg Zn + 60 mg Fe + 250 microg folic acid)
Trial: 18614736
Drug: Control (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (60 mg Fe + 250 microg folic acid)
Trial: 31220365
Drug: Screening and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Screening and treatment for fracture risk
Trial: 19652068
Drug: Chlorambucil 0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorambucil 0.8 mg/kg orally on days 1 and 15, repeated every 4 weeks for a maximum of six cycles.
Trial: 20926522
Drug: Treatment (not
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment (not specified)
Trial: 17472863
Drug: Transdermal patch
RxNorm normalized name: TRANSDERMAL PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal patch
Trial: 11417777
Drug: Inhaled nicotine
RxNorm normalized name: nicotine Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nicotine
Trial: 2544254
Drug: Central parenteral
RxNorm normalized name: Rauwolfia alkaloids, centrally acting antiadrenergic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Central parenteral nutrition (CPN)
Trial: 31209560
Drug: Oral vitamin
RxNorm normalized name: vitamin A Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vitamin A supplementation (10,000 IU/dose; n=98)
Trial: 28506228
Drug: Pulian ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulian ointment
Trial: 12656905
Drug: Cinnoxicam (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinnoxicam (30 mg suppository every 4 days for 12 months)
Trial: 12656905
Drug: Placebo (glycerine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (glycerine suppository every 4 days for 12 months)
Trial: 8625641
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no availability of daily itemized patient charges)
Trial: 6377610
Drug: Other factors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other factors (blood transfusion, preformed antibodies, graft number, recipient sex)
Trial: 25072976
Drug: Control treatment
RxNorm normalized name: SALICYLIC ACID 190 mg in 1 mL TOPICAL LIQUID [Derma E Acne Blemish Control Treatment Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control treatment (general wrapping)
Trial: 20622362
Drug: Concurrent chemoradiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent chemoradiation (Cisplatinum 40 mg/m2 and 5 Fluorouracil 500 mg/m2 continuous infusions with radiotherapy on D2-D5 in first and last 5 sessions of radiation therapy)
Trial: 20622362
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (Concurrent chemoradiation and Control)
Trial: 12372041
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose tacrolimus (trough 5-10 ng/mL)
Trial: 9522106
Drug: System I
RxNorm normalized name: Renin-angiotensin system inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: System I (investigational testosterone transdermal system)
Trial: 7652966
Drug: No thrombolytic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No thrombolytic therapy (Control)
Trial: 2540099
Drug: Non-steroidal anti-inflammatory
RxNorm normalized name: Non-steroidal anti-inflammatory agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-steroidal anti-inflammatory agents (NSAIA)
Trial: 24943252
Drug: Adaptive Iterative
RxNorm normalized name: ADAPT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adaptive Iterative Dose Reduction (AIDR) 3D
Trial: 30095550
Drug: Ketamine (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (0.4 mg/kg)
Trial: 8737615
Drug: Oral estradiol
RxNorm normalized name: estradiol Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral estradiol
Trial: 16827813
Drug: R216073 (2,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R216073 (2,000 mg)
Trial: 1400057
Drug: All groups
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All groups (including ibuprofen, pentoxifylline, and control)
Trial: 22492565
Drug: Cognitive behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioural self‐help treatment (online)
Trial: 7552591
Drug: 50 mcg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mcg/kg loading dose of diamorphine
Trial: 7552591
Drug: 200 mcg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mcg/kg loading dose of diamorphine
Trial: 3065875
Drug: Dydrogesterone 10
RxNorm normalized name: dydrogesterone 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dydrogesterone 10 mg twice daily from the 12th day until onset of the following menstrual period
Trial: 25853384
Drug: Cervical administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cervical administration of radiocolloid and blue dye (Group 1)
Trial: 20593635
Drug: Adjunctive Periochip
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive Periochip (chlorhexidine) with scaling and root planing
Trial: 9776411
Drug: Tamoxifen 10
RxNorm normalized name: tamoxifen 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen 10 mg/alternate days
Trial: 7531109
Drug: Cetirizine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetirizine (10 mg twice daily for 3 days)
Trial: 12189744
Drug: Permixon 320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Permixon 320 mg per day
Trial: 12189744
Drug: Tamsulosin 0.4
RxNorm normalized name: tamsulosin 0.4 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin 0.4 mg per day
Trial: 18783114
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) with an infrared laser (830nm, 500mW, 20s, 4J/point), once a week for four consecutive weeks.
Trial: 18783114
Drug: Placebo treatment,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment, once a week for four consecutive weeks.
Trial: 10442192
Drug: Cisplatin with
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin with amifostine (740 mg/m2)
Trial: 30939592
Drug: d-methadone (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-methadone (single doses up to 150 mg)
Trial: 30939592
Drug: d-methadone (daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-methadone (daily doses up to 75 mg for 10 days)
Trial: 30939592
Drug: d-methadone (higher
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-methadone (higher doses)
Trial: 30939592
Drug: d-methadone (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-methadone (60 mg or above)
Trial: 25607118
Drug: LifeWave Energy
RxNorm normalized name: Senergy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LifeWave Energy Enhancer (LEE) patches
Trial: 21681064
Drug: TreSPE treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TreSPE treatment (treadmill training, stretching, respiratory, and proprioceptive exercise) twice a week for 8 weeks
Trial: 21681064
Drug: TreSPE treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TreSPE treatment
Trial: 19224764
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy with procarbazine, lomustine, and vincristine
Trial: 14568832
Drug: Er:YAG laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Er:YAG laser pretreatment plus 4% lidocaine cream
Trial: 28950157
Drug: Group-based multicomponent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group-based multicomponent treatment (GMT)
Trial: 24813065
Drug: L-methylfolate 15
RxNorm normalized name: L-METHYLFOLATE 15MG CAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-methylfolate 15 mg/d for 60 days
Trial: 22914396
Drug: Pessary therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pessary therapy
Trial: 17067621
Drug: Mason-Likar (ML)
RxNorm normalized name: Oncorhynchus masou sperm DNA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mason-Likar (ML) 12-lead ECG
Trial: 9728982
Drug: Heparin-coated stent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-coated stent implantation
Trial: 3276642
Drug: No shampoos,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No shampoos, surgical preparation with chlorhexidine
Trial: 3276642
Drug: Shampoos with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shampoos with iodophor, surgical preparation with iodophor
Trial: 3276642
Drug: No shampoos,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No shampoos, surgical preparation with iodophor
Trial: 31308263
Drug: Bilateral ultrasound-guided
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bilateral ultrasound-guided transmuscular quadratus lumborum block with 30 mL ropivacaine 0.375%
Trial: 29097935
Drug: Individualized contrast
RxNorm normalized name: Contrased
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individualized contrast medium injection protocol (G1)
Trial: 29097935
Drug: Standard contrast
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard contrast medium injection (G2)
Trial: 12660683
Drug: Candesartan cilexetil
RxNorm normalized name: Candesartan Cilexetil
DrugBank: Candesartan cilexetil (DB00796)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Candesartan cilexetil 4 mg
Trial: 1703611
Drug: ANP (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ANP (0.1 mg i.v. as a bolus)
Trial: 124394
Drug: Perforated cellophane
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perforated cellophane dressing without additional medication
Trial: 30668833
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline catheter lock solution (NSCLS)
Trial: 26368824
Drug: MRK Ad5
RxNorm normalized name: mirikizumab-mrkz
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MRK Ad5 gag/pol/nef subtype B HIV‐1 preventive vaccine
Trial: 24140372
Drug: Heparin-coated foldable
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-coated foldable intraocular lens (Polylens EC‐1YH PAL)
Trial: 9753234
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg daily for eight weeks + Rebamipide 300 mg three times a day for eight weeks (group OR)
Trial: 9753234
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg daily for eight weeks + Amoxicillin 1500 mg three times a day for the first two weeks (group OA)
Trial: 7992465
Drug: Casodex (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Casodex (50 mg daily)
Trial: 3416419
Drug: Allerglobuline (10%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allerglobuline (10% human immunoglobulin preparation of placental origin)
Trial: 3416419
Drug: Placebo (10%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (10% human albumin solution)
Trial: 18301905
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline injection (control)
Trial: 28202842
Drug: 10 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g/d of trehalose
Trial: 20387996
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg EPs 7630 tablets three times a day (30‐mg group)
Trial: 17914002
Drug: Quality improvement
RxNorm normalized name: tetracaine
DrugBank: Tetracaine (DB09085)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Quality improvement interventions (education and resources for medication management or psychotherapy) for 6 to 12 months
Trial: 1806376
Drug: Ticlopidine 250
RxNorm normalized name: ticlopidine 250 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticlopidine 250 mg b.i.d.
Trial: 27435979
Drug: LY2940094 (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LY2940094 (40 mg/d)
Trial: 24216403
Drug: Intravenous lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous lidocaine infusion (1.5‐mg/kg bolus followed by 2‐mg/kg/h infusion)
Trial: 12085075
Drug: Eye patch
RxNorm normalized name: eye patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eye patch
Trial: 12085075
Drug: No eye
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No eye patch
Trial: 8678249
Drug: Propofol (starting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (starting with 9 mg.kg‐1 h‐1, reducing to 6 mg.kg‐1 h‐1 after 20 min)
Trial: 8142195
Drug: Verapamil (240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (240 mg twice daily)
Trial: 398483
Drug: Amoxycillin (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxycillin (250 mg every 8 hours for 7 to 10 days)